-
a highly collaborative research environment involving Inria, the University of Lille, Inserm and Lille University Hospital. The position is based at the Inria Centre at the University of Lille, in
-
at the Institute of Molecular and Cellular Pharmacology (IPMC, CNRS UMR7275, Inserm 1323, Université Côte d'Azur) within the Non-coding Genome & Lung Diseases research team. Jérémie Roux's group develops innovative
-
Cardioembolic Stroke Risk Stratification using AI Accelerated Patient-Specific Blood Flow Simulation
thrombogenesis. In this PhD project at Inria, in collaboration with the iCV team from Laboratoire d'Imagerie Biomédicale-LIB (Sorbonne University, Inserm), and the M2P2 team (Aix-Marseille University), we will
-
sheltered foundation under the Fondation Bordeaux Université, the VBHI is supported by its founders (University of Bordeaux, Bordeaux University Hospital, Inserm, Inria, and the Nouvelle-Aquitaine Region) and